er ways to isolate and enrich cells that result in higher cell yield, faster processing time, ease of use and are also more likely to meet future regulatory requirements," stated Judy Angelbeck, Ph.D., Senior Vice President, Pall New Technologies. "Pall was able to translate its material science expertise on the interactions between media and cells based on our long-standing leadership in blood filtration to develop this new approach to cell harvesting."
The Pall system can be used to harvest cells from a broad range of biological samples including peripheral blood, bone marrow and umbilical cord blood. The Company is currently working with several companies in applying its filter harvest system to the development of innovative cell-based therapies in a variety of therapeutic areas, including orthopedics.
"We are pleased that Pall technology can play a key role in the revolutionary advances now occurring in medicine by providing researchers with the tools to take novel cell therapies from the laboratory into the clinic, as part of our goal to make cell therapy safe, routine and simple," Dr. Angelbeck added.
Regenerative medicine, which includes cell therapy, is a promising area of scientific research with application in the treatment and cure of a rapidly expanding list of diseases and injuries. Scientists believe cell-based therapies could be used to repair damaged heart muscle following a heart attack, replace skin for burn victims, restore movement after a spinal cord injury and regenerate pancreatic tissue to produce insulin for people with diabetes. Regenerative medicine promises to improve health and quality of life by supporting and activating the body's natural healing abilities.
Page: 1 2 Related biology news :1
. Novel technology detects human DNA mutations2
. Novel antiviral technology inhibits RSV infection in mice3
. The BIOS Initiative - open source biotechnology is born4
. Revolutionary nanotechnology illuminates brain cells at work5
. Study: homemade gene expression technology unreliable6
. First technology to remove prions that cause vCJD from blood launched7
. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research8
. Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma9
. Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs10
. First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology11
. Vietnam war technology could aid elephant conservation